Reorganization and job cuts at Boiron in France

Laboratoires Boiron announces a reorganization of its activity in France, mainly affecting its common-name homeopathy segment. This measure follows the delisting of homeopathy by Health Insurance, which caused a drop in sales of more than 100 million euros in five years. Thus, volumes have been reduced by a third since 2020.

The project provides for the elimination of 145 positions, divided between the closure of four distribution establishments and seven preparatory ones, as well as the reduction of medical visit activity. At the same time, eight positions will be created for Homeopathy Development Managers.

To mitigate the social impact, Boiron is proposing support measures including voluntary departures and reassignments.